Calculate your body mass index (BMI)
Parkinson's - 240636
Study dates flexible
● Parkinson's Disease
Up to: $2,050
Male, Female, Smoker, Non-Smoker
This study is for patients with definite idiopathic PD taking oral PD medication. The purpose of this study is to learn about the safety, tolerability, and pharmacokinetics (the amount of drug exposure in your body determined through blood tests) of ABBV-951 at four dose levels in patients with Parkinson’s Disease given as 72 hour subcutaneous (under your skin)infusions using infusion sets and syringe pumps. To take part, you will be required to complete 1 screening visit. If you qualify after the screening visit, site staff will contact you regarding when you will be able to start the study.